Form 4: DocGo CFO Reports RSU Grant and Tax-Related Share Sale
Insider Transaction Report
DocGo Inc.'s CFO and Treasurer, Norman Rosenberg, reported the acquisition of 429,405 restricted stock units and the disposition of 65,774 shares for tax obligations.
Summary
- Norman Rosenberg, DocGo Inc.'s CFO and Treasurer, acquired 429,405 restricted stock units (RSUs) on December 12, 2025, as part of the Issuer's 2021 Stock Incentive Plan.
- These newly acquired RSUs will vest in four equal annual installments, beginning on December 12, 2026.
- On December 15, 2025, Rosenberg disposed of 65,774 shares of common stock at a price of $0.91 per share to satisfy tax liabilities related to previously granted RSUs.
- Following these transactions, Rosenberg's direct beneficial ownership stands at 1,223,571 shares of common stock.
- His total beneficial ownership also includes 259,546 RSUs vesting in three equal annual installments from December 12, 2026, and 191,860 RSUs vesting in two equal annual installments from December 12, 2026.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive due to the significant RSU grant, which aligns executive incentives with long-term company performance. The share disposition is a routine tax-related event and does not indicate a negative outlook.
Positives
- The grant of 429,405 restricted stock units aligns management's interests with long-term shareholder value through future vesting schedules.
Negatives
- The disposition of 65,774 shares, even for tax purposes, slightly reduces the direct beneficial ownership of a key executive.
Future Outlook
The acquired restricted stock units (RSUs) will vest in four equal annual installments starting December 12, 2026. Additionally, other existing RSUs will vest in three equal annual installments from December 12, 2026, and two equal annual installments from December 12, 2026, aligning the executive's compensation with future company performance.
Industry Context
This filing is a routine insider transaction report and does not provide specific details related to broader industry trends or competitive landscape. It reflects standard executive compensation practices involving equity grants and tax-related share dispositions.
Stakeholder Impact
- Shareholders: The RSU grant reinforces management's alignment with shareholder interests, as the value of the RSUs is tied to the company's stock performance. The tax-related sale is a common occurrence and generally has minimal impact on shareholder perception.
- Employees: The use of the 2021 Stock Incentive Plan for executive compensation indicates ongoing equity-based incentive programs within the company.
Next Steps
- Vesting of 429,405 RSUs in four equal annual installments starting December 12, 2026.
- Vesting of 259,546 RSUs in three equal annual installments starting December 12, 2026.
- Vesting of 191,860 RSUs in two equal annual installments starting December 12, 2026.
Key Dates
| Date | Description |
|---|---|
| 12/12/2025 | Date of acquisition of 429,405 Restricted Stock Units (RSUs). |
| 12/15/2025 | Date of disposition of 65,774 shares for tax liability. |
| 12/16/2025 | Date the Form 4 was signed by Attorney-in-Fact for Norman Rosenberg. |
| 12/12/2026 | First vesting date for 429,405 RSUs (first of four equal annual installments), and first vesting date for 259,546 RSUs (first of three equal annual installments), and first vesting date for 191,860 RSUs (first of two equal annual installments). |
| 12/12/2027 | Second vesting date for 429,405 RSUs, second vesting date for 259,546 RSUs, and second vesting date for 191,860 RSUs. |
| 12/12/2028 | Third vesting date for 429,405 RSUs and third vesting date for 259,546 RSUs. |
| 12/12/2029 | Fourth vesting date for 429,405 RSUs. |
Recommendation
holdThis Form 4 filing details routine insider transactions involving an RSU grant and a tax-related share disposition. While the RSU grant is a positive for management alignment, the tax sale is a standard event and does not signal a change in the company's fundamental outlook or the executive's confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
DocGo, DCGO, Norman Rosenberg, CFO, Restricted Stock Units, RSU, Insider Transaction, Form 4, Stock Incentive Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.